Tor McCaul – Managing Director – Comet Ridge Limited (ASX: COI) is a publicly listed Australian energy company focused on the development of natural ga
Copyright 2023 – Finance News Network
Source: Finance News Network
05 Jul 2021 - icetana Limited (ASX:ICE) CEO & Managing Director Matt Macfarlane talks about the company's AI software, which dramatically improves active security monitoring by learning normal movement patterns and highlighting abnormal movement in real time.
Read More29 Sep 2020 - Elixinol Global Limited (ASX:EXL) CEO Oliver Horn provides an updates on trading conditions across the company's key markets, its new distribution agreement in the UK with the Well Pharmacy Group, and early success with its CBD (cannabidiol ) skincare range.
Read More27 June 2025 - A look at The Perth Mint's services and investment offerings, from bullion to ASX-listed products.
Read More25 Sep 2023 - Wally Graham of Resources Roadhouse at the New World Metals Conference, speaking with Andy Tudor, Managing Director of Nexus Minerals (ASX:NXM).
Read More16 Aug 2023 - Tom Spurling - Executive Director - Nova Eye Medical (ASX:EYE) is introducing a comprehensive portfolio of novel glaucoma treatment options which span the entire disease process – enabling physicians to intervene earlier, and more often, in the treatment of glaucoma.
Read More12 May 2025 - Chairman James Walker discusses funding, contracts, and commercial momentum for 2025.
Read More01 Nov 2019 - IVE Group Limited (ASX:IGL) Executive Chairman, Geoff Selig talks about FY19 results, trends strategy and FY20 outlook.
Read More16 Sep 2019 - AdAlta Limited (ASX:1AD) Executive Chairman, Dr Paul MacLeman talks about the company's collaboration with GE Healthcare.
Read More10 Mar 2022 - Blair Kirkhope, Head of Specialist Investments at Sequoia Financial Group (ASX:SEQ), discusses trends in investment markets, inflation, and asset classes and sectors to watch.
Read More16 Jun 2020 - Zelira Therapeutics Limited (ASX:ZLD) Managing Director Ex USA, Dr Richard Hopkins talks about the company's pipeline of products in clinical development targeting insomnia, chronic pain and autism, its model for rapid commercialisation, its go-to-market strategy and first revenues from US licensing partners.
Read More
